SURGEX(TM) Expects to Expand Brand Awareness with the Strategic Placement of Banners during this Nationally Televised PGA Tour Event. Six Members of this Year's Field utilize SURGEX(TM) to Compliment Their Training Programs
BASKING RIDGE, N.J., March 13 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) announced today that many PGA players and spectators will be introduced to the Surgex line of products at this week's 2008 Arnold Palmer Invitational presented by MasterCard. As a tournament sponsor, the SURGEX(TM) brand name and website, http://www.surgexsports.com, will be difficult to miss while players, spectators, and media roam the fairways of one of the PGA Tour's premier events. This week's event highlights six members of the esteemed field of golfers committed to incorporating SURGEX(TM) into their daily training routines, including this year's Mayakoba Golf Classic Champion Brian Gay.
PGA and Nationwide Tour player D.A. Points, who will be wearing SURGEX(TM) name and logo apparel this week, commented, "To be able to compete with the best golfers in the world I need to be physically prepared week in and week out. Weight training and using SURGEX(TM) is a regular part of my pre- tournament preparations."
Heading the list of competitors the week is the World No. 1 Tiger Woods, who comes home riding a PGA TOUR in streak of four coupled with a victory in Dubai last month. Tiger will attempt to tie Ben Hogan who is next in line on the wins ladder. A win this week would be his 5th title in Arnie's event. Vijay Singh, the defending champion, will also be attempting a wins record of his own; a victory would give him 32 career wins and put him first on the all- time list of intentional winners.
SURGEX(TM) decided to support Mr. Palmer's tournament to highlight its commitment to sport and increase its recognition among some of the most talented athletes in the world. Millennium is encouraged by the growing number of professional athletes and teams choosing to incorporate SURGEX(TM) into their training regimens.
The Arnold Palmer Invitational will be nationally televised by NBC on Saturday and Sunday, and the Golf Channel on Thursday and Friday this week. Check local listings for times in your area.
SURGEX(TM) (http://www.surgexsports.com) was created from Millennium's extensive experience providing advanced nutritional formulas to some of the most prestigious medical institutions throughout the United States The proprietary SURGEX(TM) formula intends to meet the growing demand of elite level professional and amateur athletes and their coaches looking for nutritional support in a marketplace dominated by products with no clinical proof of benefit, unsubstantiated claims, excess protein, stimulants, and banned substances.
In double blind placebo controlled trials at the Rutgers University Human Performance Lab SURGEX(TM) significantly outperformed leading competitive products by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances.
Millennium's six marketed products form the Company's advanced line of nutritional formulas. Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium also created SURGEX(TM) sports nutrition formula, clinically proven to address the nutritional concerns of professional, Olympic, and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. Millennium's most recent formula is a contribution to the long term care market. Resurgex Essential(TM) and Resurgex Essential Plus(TM) are comprehensive, calorically dense formulas that meet and succeed the nutritional requirements of the assisted living community.
Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward- looking statements including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ("SEC"). These statements have not been evaluated by the Food and Drug Administration. Resurgex(R), Resurgex Plus(R), Resurgex Select(R) and Surgex(TM) are not intended to diagnose, treat, cure, or prevent and disease.
|SOURCE Millennium Biotechnologies Inc.|
Copyright©2008 PR Newswire.
All rights reserved